Insulin resistance and inflammation - A further systemic complication of COPD.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementAssessment of Risk in Chronic Airways Disease Evaluation (ARCADE): Protocol and preliminary data.Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease.Proteasome activity related with the daily physical activity of COPD patientsSystemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?Evaluation of exogenous melatonin administration in improvement of sleep quality in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatMetabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary diseaseParadoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in JapanGlucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scoresDecline in lung function rather than baseline lung function is associated with the development of metabolic syndrome: A six-year longitudinal study.NF-κB-dependent airway inflammation triggers systemic insulin resistance.Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.Comparison of frequency of insulin resistance in patients with chronic obstructive pulmonary disease with normal controls.Association of metabolic syndrome with chronic obstructive pulmonary disease in an Indian population.Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene.Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease (COPD) and old age?Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.COPD and the metabolic syndrome: an intriguing association.How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis.Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach?Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease.Relationship between pulmonary function and elevated glycated hemoglobin levels in health checkups: A cross-sectional observational study in Japanese participants.Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.Non-invasive ventilation abolishes the IL-6 response to exercise in muscle-wasted COPD patients: a pilot study.Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities.Diabetes mellitus among outpatients with COPD attending a university hospital.Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD.Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study.Central Fat and Peripheral MuscleLung Function and Aortic Calcification–Hardening the Evidence or Inflaming the Need for Further Research?Ectopic adiposity and cardiometabolic health in COPD
P2860
Q26799659-90701393-ABD6-4AE2-B16A-A9A1B34A766CQ30845101-3FFE2A93-F68A-4896-985E-7ADF8AA57364Q33652576-94DC2590-2DA9-455A-BCD2-15BA99F1D774Q33734381-AA0F49AE-5307-41D8-A2D4-48158A6BB9DAQ33802207-EA4907AE-1D19-43D3-9B98-13E90E5C3AC2Q33878940-5214F1B9-76C0-4297-BFD5-DFD20DDBF51EQ34126821-A7F9A978-323F-4343-9EDA-45703945A16BQ34228984-13FA9EF7-0A33-49F7-AEA2-6927623F7DF6Q34442689-6BB92083-D357-4045-BDDE-FDE13449566BQ34700758-DCCB10AE-3667-47F2-A329-53B161BA3ADCQ35790167-16E5F7FF-51F7-4935-AA1F-448EF7BBA55DQ36036900-BB3F3215-E521-4396-B995-0E8CC07F3BA3Q36323981-E3CC46AB-7F99-4426-AE39-232CF4F72A6EQ36339373-59C913ED-092B-4D21-9EAD-DD0ABD56E992Q36402823-1CAA808B-FC19-470D-B171-62BA5CB15A0BQ36552979-6A6AF355-CEA6-4A9B-A7F6-A4F3F5E097C9Q37102136-DCC6E005-045C-414D-AFC2-8980F10BA036Q37187270-A453CF47-28DF-45BA-BF43-2813A0ECBB04Q37828179-6846FB4C-6635-4E69-89BE-C13A0299D4E9Q37877440-09D3F059-3B46-4823-9EC7-301843AA212AQ37940008-FD77CF55-68B1-41E1-ADE8-ABD889B9EC1DQ37941499-B38DF828-AAFE-4617-8ABD-8242D3025431Q38068890-BEB0A9D7-FD1D-43D7-A34D-34B243B51AB0Q38580083-50FC8210-5BF1-4CE1-98C0-70D56AC5A613Q38604749-FE35650D-3DDD-4D85-8809-46FF865D3C28Q41039563-5F7ADFF8-1678-40A8-B987-6D62AABFB977Q41665936-3C59CDA1-8B8C-478F-834E-5345A7D9F382Q44609561-6BD3E411-0628-417B-BE98-E7E0D4E55EA9Q44956259-B4D5F3D6-D99D-4018-ACAE-B3DD14506D61Q47603731-0CBE28FC-E8E2-4344-91D9-BFD827C482DBQ47893382-C761DF69-BB55-428C-9B94-3F88E3B47E22Q48525384-F2A25976-E6E0-471D-A7AA-0E5C6E95C1E8Q50698868-37C65A45-2EC6-4024-8E03-0C881FE427B5Q50883932-47ED6A89-94FA-4C4D-AB6D-5A6576AB98E0Q51312447-70ADB00D-311F-4264-B836-125F34C24FCCQ56507512-AC14DB8C-58E5-4094-8416-518067BA871FQ58057582-0135DCF2-DB17-4A13-AFFE-7E8988691504Q58563190-EA0D1108-8D19-4646-8D5F-99190D99472E
P2860
Insulin resistance and inflammation - A further systemic complication of COPD.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Insulin resistance and inflammation - A further systemic complication of COPD.
@en
Insulin resistance and inflammation - A further systemic complication of COPD.
@nl
type
label
Insulin resistance and inflammation - A further systemic complication of COPD.
@en
Insulin resistance and inflammation - A further systemic complication of COPD.
@nl
prefLabel
Insulin resistance and inflammation - A further systemic complication of COPD.
@en
Insulin resistance and inflammation - A further systemic complication of COPD.
@nl
P2093
P2860
P50
P1476
Insulin resistance and inflammation - A further systemic complication of COPD
@en
P2093
P2860
P304
P356
10.1080/15412550701341053
P407
P577
2007-06-01T00:00:00Z